Abstract
BackgroundOver 70% of the patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage and lose the opportunity for radical surgery. Combination therapy of tyrosine kinase inhibitors (TKIs) and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have